The University of Queensland

Using single patient trials to determine the effectiveness of psychostimulants in fatigue in advanced cancer patients

Mitchell, Geoffrey, Hardy, Janet, Vora, Rohan, Currow, David, Schluter, Philip, Nikles, Jane and Yelland, Michael (2008). Using single patient trials to determine the effectiveness of psychostimulants in fatigue in advanced cancer patients. Herston, QLD Brisbane:

Cancer pain

Hardy, Janet, Bennett, Sally, Mitchell, Geoffrey and Strong, Jenny (2023). Cancer pain. Pain: a textbook for health professionals. (pp. 337-351) edited by Hubert van Griensven and Jenny Strong. London, United Kingdom: Elsevier.

Palliation of nausea and vomiting

Hardy, Janet R., Glare, Paul, Yates, Patsy and Mannix, Kathryn A. (2015). Palliation of nausea and vomiting. Oxford textbook of palliative medicine. (pp. 661-674) edited by Nathan Cherny, Marie Fallon, Stein Kaasa, Russell K. Portenoy and David C. Currow. Oxford, United Kingdom: Oxford University Press. doi: 10.1093/med/9780199656097.003.0202

Opioid analgesics for severe cancer pain

Good, Phillip and Hardy, Janet (2012). Opioid analgesics for severe cancer pain. Analgesics for cancer pain. (pp. 31-40) edited by Frank Porecca and Tamara King. London, United Kingdom: Future Medicine. doi: 10.2217/EBO.11.288

Symptom management in the last days of life

Librach, S. Lawrence and Hardy, Janet R. (2011). Symptom management in the last days of life. Supportive Oncology. (pp. 398-404) Philadelphia, PA United States: Elsevier. doi: 10.1016/b978-1-4377-1015-1.00038-2

Palliative care in breast cancer

Hardy, Janet (2010). Palliative care in breast cancer. Medical therapy of breast cancer. (pp. 357-383) edited by Zenon Rayter and Janine Mansi. Cambridge, United Kingdom: Cambridge University Press. doi: 10.1017/cbo9780511545870.017

Diamorphine

Hardy, Janet R. and Quigley, Columba (2009). Diamorphine. Opioids in Cancer Pain. (pp. 263-268) Oxford University Press. doi: 10.1093/med/9780199236640.003.0016

Codeine

Hardy, Janet R. and Jackson II, Kenneth C. (2009). Codeine. Opioids in Cancer Pain. (pp. 81-88) edited by Mellar P. Davis, Paul A. Glare, Janet Hardy and Columba Quigley. Oxford, United Kingdom: Oxford University Press. doi: 10.1093/med/9780199236640.003.0005

Opioid rotation

Hardy, Janet R., Quigley, Columba and Ross, Joy R. (2009). Opioid rotation. Opioids in Cancer Pain. (pp. 301-312) edited by Mellar Davis, Paul A. Glare, Janet Hardy and Columba Quigley. Oxford, United Kingdom: Oxford University Press. doi: 10.1093/med/9780199236640.003.0020

Opioids

Nauck, Friedemann and Hardy, Janet R. (2009). Opioids. Palliative medicine. (pp. 754-759) edited by T. Declan Walsh and et al.. Philadelphia, U.S.A.: Saunders/Elsevier. doi: 10.1016/b978-0-323-05674-8.50142-0

Opioids for cancer pain

Hardy, Janet R. and Nauch, Friedemann (2009). Opioids for cancer pain. Palliative medicine. (pp. 1404-1410) edited by Declan Walsh. Philadelphia, PA, United States: Saunders/Elsevier.

Opioids for cancer pain

Hardy, Janet R. and Nauck, Friedemann (2009). Opioids for cancer pain. Palliative Medicine. (pp. 1404-1411) edited by Declan Walsh. Philadelphia, PA, United States: Elsevier.

Opioids in renal failure

Hardy, Janet R. (2009). Opioids in renal failure. Opioids in Cancer Pain. (pp. 69-80) edited by Mellar P. Davis, Paul A. Glare , Janet Hardy and Columba Quigley. Oxford, United Kingdom: Oxford University Press. doi: 10.1093/med/9780199236640.003.0004

Opioids in the terminal phase

Hardy, Janet R. (2009). Opioids in the terminal phase. Opioids in Cancer Pain. (pp. 455-460) edited by Mellar P. Davis, Paul A. Glare, Janet Hardy and Columba Quigley. Oxford, United Kingdom: Oxford University Press. doi: 10.1093/med/9780199236640.003.0029

Principles of palliative medicine research

Hardy, Janet, White, Clare and Glare, Paul (2009). Principles of palliative medicine research. Palliative medicine. (pp. 136-143) edited by T. Declan Walsh and et al.. Philadelphia, U.S.A.: Saunders, Elsevier. doi: 10.1016/b978-0-323-05674-8.50030-x

The lipophilic opioids: fentanyl, alfentanil, sufentanil, and remifentanil

Hall, Anthony and Hardy, Janet R. (2009). The lipophilic opioids: fentanyl, alfentanil, sufentanil, and remifentanil. Opioids in Cancer Pain. (pp. 175-192) edited by Mellar P. Davis, Paul A. Glare, Janet Hardy and Columba Quigley. Oxford, United Kingdom: Oxford University Press. doi: 10.1093/med/9780199236640.003.0011

Symptom Management in Palliative Care

Hardy, J. and Yates, P. (2008). Symptom Management in Palliative Care. Palliative Care: A patient centered approach. (pp. 109-125) edited by Walsh, G.. Oxford UK: Radcliffe Publishing.

Palliative care in breast cancer

Hardy, Janet (2006). Palliative care in breast cancer. Breast surgery. (pp. 215-234) edited by J. Michael Dixon. Elsevier Saunders: Philadelphia, Pa., U.S.A..

Codeine

Hardy, Janet R. (2005). Codeine. Opioids in cancer pain. (pp. 53-58) edited by Mellar Davis, Paul Glare and Janet Hardy. Oxford, U.K.: Oxford University Press.

Diamorphine

Hardy, Janet R. (2005). Diamorphine. Opioids in cancer pain. (pp. 207-214) edited by Mellar Davis, Paul Glare and Janet Hardy. Oxford, U.K.: Oxford University Press.

Opioid rotation

Hardy, Janet R. (2005). Opioid rotation. Opioids in cancer pain. (pp. 235-246) edited by Mellar Davis, Paul Glare and Janet Hardy. Oxford, U.K.: Oxford University Press.

The lipophillic opioids: fentanyl, alfentanil, sufentanil and remifentanil

Hall, Tony and Hardy, Janet R. (2005). The lipophillic opioids: fentanyl, alfentanil, sufentanil and remifentanil. Opioids in cancer pain. (pp. 155-172) edited by Mellar Davis, Paul Glare and Janet Hardy. Oxford, U.K.: Oxford University Press.

Palliative care in paediatric oncology

Hain, Richard and Hardy, Janet (2004). Palliative care in paediatric oncology. Paediatric Oncology, Third edition. (pp. 684-703) CRC Press. doi: 10.1201/b13276-39

Food and hydration

Hardy, Janet, White, Helen, Henry, Louise and Oliver, David (2004). Food and hydration. Palliative care in neurology. (pp. 335-348) edited by Raymond Voltz, James L. Bernat, Gian Domenico Borasio, Ian Maddocks, David Oliver and Russell K. Portenoy. Oxford, U.K.: Oxford University Press.

Neurological Emergencies

Hardy, J. and Martin, D. (2004). Neurological Emergencies. Palliative Care in Neurology. (pp. 283-290) edited by Raymond Voltz, James L. Bernat, Gian Domenico Borasio, Ian Maddocks, David Oliver and Russell K. Portenoy. New York, United States: Oxford University Press.

Palliative care in paediatric oncology

Hain, R. D. and Hardy, Janet R. (2004). Palliative care in paediatric oncology. Paediatric oncology. (pp. 684-704) edited by Ross Pinkerton, Piers N. Plowman and Rob Pieters. London: Arnold.

Exploring potential anti-inflammatory effects of medicinal cannabis

Gurgenci, Taylan, Kijanka, Gregor, Greer, Ristan, Huggett, Georgie, Good, Phillip, Moniruzzaman, Md and Hardy, Janet (2023). Exploring potential anti-inflammatory effects of medicinal cannabis. Supportive Care in Cancer, 31 (12) 629, 629. doi: 10.1007/s00520-023-08069-8

Quality of life beyond measure: Advanced cancer patients, wellbeing and medicinal cannabis

Smith, Alexandra, Olson, Rebecca E., da Costa, Nathalia Cordeiro, Cuerton, Maddison, Hardy, Janet and Good, Philip (2023). Quality of life beyond measure: Advanced cancer patients, wellbeing and medicinal cannabis. Sociology of Health & Illness, 45 (8), 1709-1729. doi: 10.1111/1467-9566.13684

Results from a type two hybrid‐effectiveness study to implement a preoperative anemia and iron deficiency screening, evaluation, and management pathway

Delaforce, Alana, Farmer, Shannon, Duff, Jed, Munday, Judy, Miller, Kristin, Glover, Lynne, Corney, Chris, Ansell, Gareth, Gutta, Naadir, Tuffaha, Haitham, Hardy, Janet and Hurst, Cameron (2023). Results from a type two hybrid‐effectiveness study to implement a preoperative anemia and iron deficiency screening, evaluation, and management pathway. Transfusion, 63 (4), 724-736. doi: 10.1111/trf.17287

Corticosteroids for the management of cancer-related fatigue in adults with advanced cancer

Sandford, Amy, Haywood, Alison, Rickett, Kirsty, Good, Phillip, Khan, Sohil, Foster, Karyn and Hardy, Janet R. (2023). Corticosteroids for the management of cancer-related fatigue in adults with advanced cancer. The Cochrane Database of Systematic Reviews, 1 (1) CD013782, 1-46. doi: 10.1002/14651858.CD013782.pub2

Drug dependence epidemiology in palliative care medicinal cannabis trials

Lee, Chee Yen, Good, Phillip, Huggett, Georgie, Greer, Ristan and Hardy, Janet (2023). Drug dependence epidemiology in palliative care medicinal cannabis trials. BMJ Supportive and Palliative Care spcare-2023-004583, spcare-2023. doi: 10.1136/spcare-2023-004583

Association of KCNJ6 rs2070995 and methadone response for pain management in advanced cancer at end-of-life

Ozberk, Deniz, Haywood, Alison, Sutherland, Heidi G., Yu, Chieh, Albury, Cassie L., Zunk, Mathew, George, Rani, Good, Phillip, Griffiths, Lyn R., Hardy, Janet and Haupt, Larisa M. (2022). Association of KCNJ6 rs2070995 and methadone response for pain management in advanced cancer at end-of-life. Scientific Reports, 12 (1) 17422, 1-7. doi: 10.1038/s41598-022-21180-w

Medicinal cannabis in palliative medicine: lessons learnt from randomised controlled trials

Gurgenci, Taylan, Hardy, Janet, Olson, Rebecca, Huggett, Georgie, Foster, Karyn and Good, Phillip (2022). Medicinal cannabis in palliative medicine: lessons learnt from randomised controlled trials. BMJ Supportive & Palliative Care, 13 (2) spcare-2022-004035, 1-3. doi: 10.1136/spcare-2022-004035

‘What price do you put on your health?’: Medical cannabis, financial toxicity and patient perspectives on medication access in advanced cancer

Olson, Rebecca E., Smith, Alexandra, Good, Phillip, Dudley, Morgan, Gurgenci, Taylan and Hardy, Janet (2022). ‘What price do you put on your health?’: Medical cannabis, financial toxicity and patient perspectives on medication access in advanced cancer. Health Expectations, 26 (1), 160-171. doi: 10.1111/hex.13642

Phase IIb randomized, placebo-controlled, dose-escalating, double-blind study of cannabidiol oil for the relief of symptoms in advanced cancer (MedCan1-CBD)

Hardy, Janet, Greer, Ristan M., Huggett, Georgie, Kearney, Alison, Gurgenci, Taylan and Good, Phillip (2022). Phase IIb randomized, placebo-controlled, dose-escalating, double-blind study of cannabidiol oil for the relief of symptoms in advanced cancer (MedCan1-CBD). Journal of Clinical Oncology, 41 (7), 1444-1452. doi: 10.1200/JCO.22.01632

Using a qualitative sub-study to inform the design and delivery of randomised controlled trials on medicinal cannabis for symptom relief in patients with advanced cancer

Olson, Rebecca E., Smith, Alexandra, Huggett, Georgie, Good, Phillip, Dudley, Morgan and Hardy, Janet (2022). Using a qualitative sub-study to inform the design and delivery of randomised controlled trials on medicinal cannabis for symptom relief in patients with advanced cancer. Trials, 23 (1) 752, 1-16. doi: 10.1186/s13063-022-06691-1

Research agenda for medical cannabis in palliative care

Gurgenci, Taylan, Hardy, Janet and Good, Phillip (2022). Research agenda for medical cannabis in palliative care. BMJ Supportive & Palliative Care, 12 (3) bmjspcare-2022-003747, bmjspcare-2022. doi: 10.1136/bmjspcare-2022-003747

Does cannabidiol have a benefit as a supportive care drug in cancer?

Lord, Sarah, Hardy, Janet and Good, Phillip (2022). Does cannabidiol have a benefit as a supportive care drug in cancer?. Current Treatment Options in Oncology, 23 (4), 514-525. doi: 10.1007/s11864-021-00934-0

Association of polymorphisms in ARRB2 and clinical response to methadone for pain in advanced cancer

Ozberk, Deniz, Haywood, Alison, Sutherland, Heidi G., Yu, Chieh, Albury, Cassie L, Zunk, Mathew, George, Rani, Good, Phillip, Griffiths, Lyn R., Hardy, Janet and Haupt, Larisa M (2022). Association of polymorphisms in ARRB2 and clinical response to methadone for pain in advanced cancer. Pharmacogenomics, 23 (5), 281-289. doi: 10.2217/pgs-2021-0139

Oral water-soluble contrast (Gastrografin) for malignant bowel obstruction: open label pilot study

Wan Bahrum, Wan Fadzrul Izuan Bin, Hardy, Janet, Foster, Karyn and Good, Phillip (2022). Oral water-soluble contrast (Gastrografin) for malignant bowel obstruction: open label pilot study. BMJ Supportive and Palliative Care 003444, 1-4. doi: 10.1136/bmjspcare-2021-003444

Interests and conflicts when writing, reviewing and editing papers on voluntary assisted dying

Hardy, Janet R. and Philip, Jennifer (2021). Interests and conflicts when writing, reviewing and editing papers on voluntary assisted dying. Internal Medicine Journal, 51 (10), 1563-1566. doi: 10.1111/imj.15522

Medicinal cannabis use in palliative care

Herbert, Anthony and Hardy, Janet (2021). Medicinal cannabis use in palliative care. Australian Journal of General Practice, 50 (6), 363-368. doi: 10.31128/AJGP-02-21-5831

A theoretically informed approach to support the implementation of pre-operative anemia and iron deficiency screening, evaluation, and management pathways: protocol for a type two hybrid-effectiveness study

Delaforce, Alana, Duff, Jed, Munday, Judy, Farmer, Shannon, Miller, Kristin, Glover, Lynne, Corney, Christopher, Hurst, Cameron, Ansell, Gareth, Gutta, Naadir, Tuffaha, Haitham and Hardy, Janet (2021). A theoretically informed approach to support the implementation of pre-operative anemia and iron deficiency screening, evaluation, and management pathways: protocol for a type two hybrid-effectiveness study. Journal of Multidisciplinary Healthcare, 14, 1037-1044. doi: 10.2147/jmdh.s313309

Practice review: evidence-based quality use of corticosteroids in the palliative care of patients with advanced cancer

Hardy, Janet, Haywood, Alison, Rickett, Kirsty, Sallnow, Libby and Good, Phillip (2021). Practice review: evidence-based quality use of corticosteroids in the palliative care of patients with advanced cancer. Palliative Medicine, 35 (3), 269216320986717-472. doi: 10.1177/0269216320986717

The management of nausea and vomiting not related to anticancer therapy in patients with cancer

Hardy, Janet and Davis, Mellar P (2021). The management of nausea and vomiting not related to anticancer therapy in patients with cancer. Current Treatment Options in Oncology, 22 (2) 17, 17. doi: 10.1007/s11864-020-00813-0

A randomized controlled trial of a non-pharmacological intervention for cancer-related dyspnea

Yates, Patsy, Hardy, Janet, Clavarino, Alexandra, Fong, Kwun M., Mitchell, Geoffrey, Skerman, Helen, Brunelli, Vanessa and Zhao, Isabella (2020). A randomized controlled trial of a non-pharmacological intervention for cancer-related dyspnea. Frontiers in Oncology, 10 591610, 591610. doi: 10.3389/fonc.2020.591610

Corticosteroids for the management of cancer-related fatigue in adults with advanced cancer

Haywood, Alison, Sandford, Amy, Rickett, Kirsty, Good, Phillip, Khan, Sohil and Hardy, Janet R (2020). Corticosteroids for the management of cancer-related fatigue in adults with advanced cancer. Cochrane Database of Systematic Reviews, 2020 (11) CD013782. doi: 10.1002/14651858.CD013782

Preoperative anemia screening and treatment practices in patients having total joint replacement surgery: a retrospective, observational audit

Delaforce, Alana, Galeel, Lemya, Poon, Edgar, Hurst, Cameron, Duff, Jed, Munday, Judy and Hardy, Janet (2020). Preoperative anemia screening and treatment practices in patients having total joint replacement surgery: a retrospective, observational audit. Journal of Blood Medicine, 11, 259-265. doi: 10.2147/jbm.s254116

Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: a double-blind, placebo-controlled, randomised clinical trial of efficacy and safety of 1:1 delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD)

Hardy, Janet, Haywood, Alison, Gogna, Gauri, Martin, Jennifer, Yates, Patsy, Greer, Ristan and Good, Phillip (2020). Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: a double-blind, placebo-controlled, randomised clinical trial of efficacy and safety of 1:1 delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD). Trials, 21 (1) 611, 1-8. doi: 10.1186/s13063-020-04541-6

Emotionally reflexive labour in end-of-life communication

Olson, Rebecca E., Smith, Alexandra, Good, Phillip, Neate, Emily, Hughes, Cody and Hardy, Janet (2020). Emotionally reflexive labour in end-of-life communication. Social Science and Medicine, 291 112928, 1-9. doi: 10.1016/j.socscimed.2020.112928

Stringent control of opioids: sound public health measures, but a step too far in palliative care?

Pinkerton, Ross, Mitchell, Geoffrey and Hardy, Janet (2020). Stringent control of opioids: sound public health measures, but a step too far in palliative care?. Current Oncology Reports, 22 (4) 34, 1-9. doi: 10.1007/s11912-020-0900-5

Overcoming barriers to evidence-based patient blood management: a restricted review

Delaforce, Alana, Duff, Jed, Munday, Judy and Hardy, Janet (2020). Overcoming barriers to evidence-based patient blood management: a restricted review. Implementation Science, 15 (1) 6. doi: 10.1186/s13012-020-0965-4

Preoperative anemia and iron deficiency screening, evaluation and management: barrier identification and implementation strategy mapping

Delaforce, Alana, Duff, Jed, Munday, Judy and Hardy, Janet (2020). Preoperative anemia and iron deficiency screening, evaluation and management: barrier identification and implementation strategy mapping. Journal of Multidisciplinary Healthcare, 13, 1759-1770. doi: 10.2147/JMDH.S282308

Prevalence of QTc prolongation in patients with advanced cancer receiving palliative care – a cause for concern?

Hardy, Janet R., Bundock, Daniel, Cross, Jessica, Gibbons, Kristen, Pinkerton, Ross, Kindl, Korana, Good, Phillip and Philip, Jennifer (2019). Prevalence of QTc prolongation in patients with advanced cancer receiving palliative care – a cause for concern?. Journal of Pain and Symptom Management, 59 (4), 856-863. doi: 10.1016/j.jpainsymman.2019.12.356

Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: a double-blind, placebo controlled, randomised clinical trial of efficacy and safety of cannabidiol (CBD)

Good, Phillip, Haywood, Alison, Gogna, Gauri, Martin, Jennifer, Yates, Patsy, Greer, Ristan and Hardy, Janet (2019). Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: a double-blind, placebo controlled, randomised clinical trial of efficacy and safety of cannabidiol (CBD). BMC Palliative Care, 18 (1) 110, 110. doi: 10.1186/s12904-019-0494-6

An Open-Label Pilot Study Testing the Feasibility of Assessing Total Symptom Burden in Trials of Cannabinoid Medications in Palliative Care

Good, Phillip D., Greer, Ristan M., Huggett, Georgina E. and Hardy, Janet R. (2019). An Open-Label Pilot Study Testing the Feasibility of Assessing Total Symptom Burden in Trials of Cannabinoid Medications in Palliative Care. Journal of Palliative Medicine, 23 (5) jpm.2019.0540, 650-655. doi: 10.1089/jpm.2019.0540

Methotrimeprazine versus haloperidol in palliative care patients with cancer-related nausea: a randomised, double-blind controlled trial

Hardy, Janet Rea, Skerman, Helen, Philip, Jennifer, Good, Phillip, Currow, David C, Mitchell, Geoffrey and Yates, Patsy (2019). Methotrimeprazine versus haloperidol in palliative care patients with cancer-related nausea: a randomised, double-blind controlled trial. BMJ Open, 9 (9) e029942, e029942. doi: 10.1136/bmjopen-2019-029942

Harms from Haloperidol for symptom management in palliative care — a post hoc pooled analysis of three randomized controlled studies and two consecutive cohort studies

Matsuoka, Hiromichi, Agar, Meera, Vandersman, Zac, Good, Philip, Fazekas, Belinda, Brown, Linda, Hardy, Janet, Weil, Jennifer and Currow, David Christopher (2019). Harms from Haloperidol for symptom management in palliative care — a post hoc pooled analysis of three randomized controlled studies and two consecutive cohort studies. Journal of Pain and Symptom Management, 58 (3), e6-e8. doi: 10.1016/j.jpainsymman.2019.05.004

Quality use of medicines: oral corticosteroids in advanced cancer

Pinkerton, Eve, Good, Phillip, Kindl, Korana, Richard, Russell, Fischer, Amanda and Hardy, Janet R. (2019). Quality use of medicines: oral corticosteroids in advanced cancer. Palliative Medicine, 33 (10), 269216319866647-1326. doi: 10.1177/0269216319866647

Managing diabetes at the end of life – a retrospective chart audit of two health providers in Queensland, Australia

Alqabandi, Naeema, Haywood, Alison, Kindl, Korana, Khan, Sohil, Good, Phillip and Hardy, Janet (2019). Managing diabetes at the end of life – a retrospective chart audit of two health providers in Queensland, Australia. Progress in Palliative Care, 27 (2), 1-7. doi: 10.1080/09699260.2019.1611721

Assessing quality of life in palliative care settings: head-to-head comparison of four patient-reported outcome measures (EORTC QLQ-C15-PAL, FACT-Pal, FACT-Pal-14, FACT-G7)

King, Madeleine T., Agar, Meera, Currow, David C., Hardy, Janet, Fazekas, Belinda and McCaffrey, Nikki (2019). Assessing quality of life in palliative care settings: head-to-head comparison of four patient-reported outcome measures (EORTC QLQ-C15-PAL, FACT-Pal, FACT-Pal-14, FACT-G7). Supportive Care in Cancer, 28 (1), 141-153. doi: 10.1007/s00520-019-04754-9

Systemic corticosteroids for the management of cancer-related breathlessness (dyspnoea) in adults

Haywood, Alison, Duc, Jacqueline, Good, Phillip, Khan, Sohil, Rickett, Kirsty, Vayne-Bossert, Petra and Hardy, Janet R. (2019). Systemic corticosteroids for the management of cancer-related breathlessness (dyspnoea) in adults. Cochrane Database of Systematic Reviews, 2 (2) ARTN CD012704. doi: 10.1002/14651858.CD012704.pub2

Economic evaluation of the randomised, double-blind, placebo-controlled study of subcutaneous ketamine in the management of chronic cancer pain

McCaffrey, Nikki, Flint, Thomas, Kaambwa, Billingsley, Fazekas, Belinda, Rowett, Debra, Currow, David C, Hardy, Janet, Agar, Meera R, Quinn, Steve and Eckermann, Simon (2019). Economic evaluation of the randomised, double-blind, placebo-controlled study of subcutaneous ketamine in the management of chronic cancer pain. Palliative Medicine, 33 (1), 74-81. doi: 10.1177/0269216318801754

A randomized open-label study of guideline-driven antiemetic therapy versus single agent antiemetic therapy in patients with advanced cancer and nausea not related to anticancer treatment

Hardy, Janet, Skerman, Helen, Glare, Paul, Philip, Jennifer, Hudson, Peter, Mitchell, Geoffrey, Martin, Peter, Spruyt, Odette, Currow, David and Yates, Patsy (2018). A randomized open-label study of guideline-driven antiemetic therapy versus single agent antiemetic therapy in patients with advanced cancer and nausea not related to anticancer treatment. BMC cancer, 18 (1) 510, 510. doi: 10.1186/s12885-018-4404-8

Impact of opioid therapy on sleep and respiratory patterns in adults with advanced cancer receiving palliative care

Good, Phillip, Pinkerton, Ross, Bowler, Simon, Craig, Justin and Hardy, Janet (2018). Impact of opioid therapy on sleep and respiratory patterns in adults with advanced cancer receiving palliative care. Journal of Pain and Symptom Management, 55 (3), 962-967. doi: 10.1016/j.jpainsymman.2017.11.026

Castrate-resistant prostate cancer: lessons learnt from a pilot study in the palliative care research population

Sullivan, Karyn A, Kingi, Ngaire, Good, Phillip, Vayne-Bossert, Petra and Hardy, Janet R (2018). Castrate-resistant prostate cancer: lessons learnt from a pilot study in the palliative care research population. International Journal of Palliative Nursing, 24 (2), 96-98. doi: 10.12968/ijpn.2018.24.2.96

Integration of oncology and palliative care: setting a benchmark

Vayne-Bossert, P., Richard, E., Good, P., Sullivan, K. and Hardy, J. R. (2017). Integration of oncology and palliative care: setting a benchmark. Supportive Care in Cancer, 25 (10), 3253-3259. doi: 10.1007/s00520-017-3736-2

Neuropathic pain in cancer: systematic review, performance of screening tools and analysis of symptom profiles

Muley, M. R., Boland, E. G., Bouhassira, D. , Freynhagen, R., Hardy, J., Hjermstad, M. J. , Mercadante, S., Perez, C. and Bennett, M. I. (2017). Neuropathic pain in cancer: systematic review, performance of screening tools and analysis of symptom profiles. British Journal of Anaesthesia, 119 (4), 765-774. doi: 10.1093/bja/aex175

Corticosteroids as co-analgesics with opioids for cancer related pain: a feasibility study

Ashar, Amna, Fischer, Amanda, Hardy, Janet and Good, Phillip (2017). Corticosteroids as co-analgesics with opioids for cancer related pain: a feasibility study. Journal of Pain and Symptom Management, 54 (6), E1-E2. doi: 10.1016/j.jpainsymman.2017.09.009

Can saliva and plasma methadone concentrations be used for enantioselective pharmacokinetic and pharmacodynamic studies in patients with advanced cancer?

George, Rani, Haywood, Alison, Good, Phillip, Hennig, Stefanie, Khan, Sohil, Norris, Ross and Hardy, Janet (2017). Can saliva and plasma methadone concentrations be used for enantioselective pharmacokinetic and pharmacodynamic studies in patients with advanced cancer?. Clinical Therapeutics, 39 (9), 1840-1848. doi: 10.1016/j.clinthera.2017.07.044

Symptom clusters in men with castrate-resistant prostate cancer

Vayne-Bossert, Petra, Hardy, Janet, Skerman, Helen, Yates, Patsy, Sullivan, Karyn and Good, Phillip (2017). Symptom clusters in men with castrate-resistant prostate cancer. Journal of Pain and Symptom Management, 54 (3), e1-e3. doi: 10.1016/j.jpainsymman.2017.07.045

A retrospective audit on usage of Diatrizoate Meglumine (Gastrografin®) for intestinal obstruction or constipation in patients with advanced neoplasms

Heng, Sharon, Hardy, Janet and Good, Phillip (2017). A retrospective audit on usage of Diatrizoate Meglumine (Gastrografin®) for intestinal obstruction or constipation in patients with advanced neoplasms. Palliative Medicine, 32 (1), 294-298. doi: 10.1177/0269216317726430

Corticosteroids for adult patients with advanced cancer who have nausea and vomiting (not related to chemotherapy, radiotherapy, or surgery)

Vayne-Bossert, Petra, Haywood, Alison, Good, Phillip, Khan, Sohil, Rickett, Kirsty, Jenkins-Marsh, Sue and Hardy, Janet R. (2017). Corticosteroids for adult patients with advanced cancer who have nausea and vomiting (not related to chemotherapy, radiotherapy, or surgery). Cochrane Database of Systematic Reviews, 2017 (7) CD012002. doi: 10.1002/14651858.CD012002.pub2

Systemic corticosteroids for the management of cancer-related breathlessness (dyspnoea) in adults

Haywood, Alison, Duc, Jacqueline, Good, Phillip, Khan, Sohil, Rickett, Kirsty, Vayne-Bossert, Petra and Hardy, Janet R. (2017). Systemic corticosteroids for the management of cancer-related breathlessness (dyspnoea) in adults. Cochrane Database of Systematic Reviews, 2017 (6) CD012704. doi: 10.1002/14651858.CD012704

Opioid addiction and misuse in adult and adolescent patients with cancer

Pinkerton, Ross and Hardy, Janet (2017). Opioid addiction and misuse in adult and adolescent patients with cancer. Internal Medicine Journal, 47 (6), 632-636. doi: 10.1111/imj.13449

Efficacy of oral risperidone, haloperidol, or placebo for symptoms of delirium among patients in palliative care: a randomized clinical trial

Agar, Meera R., Lawlor, Peter G., Quinn, Stephen, Draper, Brian, Caplan, Gideon A., Rowett, Debra, Sanderson, Christine, Hardy, Janet, Le, Brian, Eckermann, Simon, McCaffrey, Nicola, Devilee, Linda, Fazekas, Belinda, Hill, Mark and Currow, David C. (2017). Efficacy of oral risperidone, haloperidol, or placebo for symptoms of delirium among patients in palliative care: a randomized clinical trial. JAMA Internal Medicine, 177 (1), 34-42. doi: 10.1001/jamainternmed.2016.7491

An open-label pilot study of oral vitamin C as an opioid-sparing agent in patients with chronic pain secondary to cancer

Pinkerton, E., Good, P., Gibbons, K. and Hardy, J. (2016). An open-label pilot study of oral vitamin C as an opioid-sparing agent in patients with chronic pain secondary to cancer. Supportive Care in Cancer, 25 (2), 1-3. doi: 10.1007/s00520-016-3472-z

Large volume subcutaneous lymphoedema drainage

Heng, S. and Hardy, J. R. (2016). Large volume subcutaneous lymphoedema drainage. Internal Medicine Journal, 46 (11), 1346-1347. doi: 10.1111/imj.13241

A pilot study of intraperitoneal bevacizumab for the palliation of malignant ascites

Jones, Joanna M., Hardy, Janet R., Munster, David J. and Shannon, Catherine M. (2016). A pilot study of intraperitoneal bevacizumab for the palliation of malignant ascites. Asia-Pacific Journal of Clinical Oncology, 13 (3), 261-262. doi: 10.1111/ajco.12578

A randomised, double-blind controlled trial of intranasal midazolam for the palliation of dyspnoea in patients with life-limiting disease

Hardy, Janet, Randall, Clare, Pinkerton, Eve, Flatley, Christopher, Gibbons, Kristen and Allan, Simon (2016). A randomised, double-blind controlled trial of intranasal midazolam for the palliation of dyspnoea in patients with life-limiting disease. Supportive Care in Cancer, 24 (7), 3069-3076. doi: 10.1007/s00520-016-3125-2

Pining for the fjords

Hardy, J. R. and Douglas, C. M. (2016). Pining for the fjords. Internal Medicine Journal, 46 (6), 651-652. doi: 10.1111/imj.13105

Interventional options for the management of refractory cancer pain-what is the evidence?

Vayne-Bossert, Petra, Afsharimani, Banafsheh, Good, Phillip, Gray, Paul and Hardy, Janet (2016). Interventional options for the management of refractory cancer pain-what is the evidence?. Supportive Care in Cancer, 24 (3), 1429-1438. doi: 10.1007/s00520-015-3047-4

Quantitative determination of the enantiomers of methadone in human plasma and saliva by chiral column chromatography coupled with mass spectrometric detection

George, Rani, Lobb, Michael, Haywood, Alison, Khan, Sohil, Hardy, Janet, Good, Phillip, Hennig, Stefanie and Norris, Ross (2016). Quantitative determination of the enantiomers of methadone in human plasma and saliva by chiral column chromatography coupled with mass spectrometric detection. Talanta, 149, 142-148. doi: 10.1016/j.talanta.2015.11.044

Single patient multiple cross-over studies to determine the effectiveness of paracetamol in relieving pain suffered by patients with advanced cancer taking regular opioids: a pilot study.

Nikles, Jane, Mitchell, Geoffrey K., Hardy, Janet, Senior, Hugh, Carmont, Sue-Ann, Schluter, Philip J., Vora, Rohan, Currow, David and Yelland, Michael (2016). Single patient multiple cross-over studies to determine the effectiveness of paracetamol in relieving pain suffered by patients with advanced cancer taking regular opioids: a pilot study.. Palliative Medicine: a multiprofessional journal, 30 (8), 1-3. doi: 10.1177/0269216316635012

Potential economic impact on hospitalisations of the Palliative Care Clinical Studies Collaborative (PaCCSC) ketamine randomised controlled trial

McCaffrey, Nikki, Hardy, Janet, Fazekas, Belinda, Agar, Meera, Devilee, Linda, Rowett, Debra and Currow, David (2016). Potential economic impact on hospitalisations of the Palliative Care Clinical Studies Collaborative (PaCCSC) ketamine randomised controlled trial. Australian Health Review, 40 (1), 100-105. doi: 10.1071/AH15012

Corticosteroids for adult patients with advanced cancer who have nausea and vomiting (not related to chemo- or radiotherapy, or surgery)(Protocol)

Vayne-Bossert, Petra, Haywood, Alison, Good, Phillip, Khan, Sohil, Rickett, Kirsty, Jenkins-Marsh, Sue and Hardy, Janet R. (2015). Corticosteroids for adult patients with advanced cancer who have nausea and vomiting (not related to chemo- or radiotherapy, or surgery)(Protocol). Cochrane Database of Systematic Reviews, 2015 (12) CD012002. doi: 10.1002/14651858.CD012002

Saliva versus plasma for pharmacokinetic and pharmacodynamic studies of fentanyl in patients with cancer

Bista, Sudeep R., Haywood, Alison, Norris, Ross, Good, Phillip, Tapuni, Angela, Lobb, Michael and Hardy, Janet (2015). Saliva versus plasma for pharmacokinetic and pharmacodynamic studies of fentanyl in patients with cancer. Clinical Therapeutics, 37 (12), 2882-2883. doi: 10.1016/j.clinthera.2015.11.002

Saliva versus plasma for pharmacokinetic and pharmacodynamic studies of fentanyl in patients with cancer

Bista, Sudeep R., Haywood, Alison, Norris, Ross, Good, Phillip, Tapuni, Angela, Lobb, Michael and Hardy, Janet (2015). Saliva versus plasma for pharmacokinetic and pharmacodynamic studies of fentanyl in patients with cancer. Clinical Therapeutics, 37 (11), 2468-2475. doi: 10.1016/j.clinthera.2015.09.002

The effect of methylphenidate on fatigue in advanced cancer: an aggregated n-of-1 trial

Mitchell, Geoffrey K., Hardy, Janet R., Nikles, Catherine J., Carmont, Sue-Ann S., Senior, Hugh E., Schluter, Philip J., Good, Philip and Currow, David C. (2015). The effect of methylphenidate on fatigue in advanced cancer: an aggregated n-of-1 trial. Journal of Pain and Symptom Management, 50 (3), 289-296. doi: 10.1016/j.jpainsymman.2015.03.009

EA versus sham acupuncture and no acupuncture for the control of acute and delayed chemotherapy-induced nausea and vomiting: a pilot study

McKeon, Chris, Smith, Caroline A., Gibbons, Kristen and Hardy, Janet (2015). EA versus sham acupuncture and no acupuncture for the control of acute and delayed chemotherapy-induced nausea and vomiting: a pilot study. Acupuncture in Medicine, 33 (4), 277-283. doi: 10.1136/acupmed-2015-010781

Testing pilocarpine drops for dry mouth in advanced cancer using n-of-1 trials: A feasibility study

Nikles, Jane, Mitchell, Geoffrey K., Hardy, Janet, Agar, Meera, Senior, Hugh Edgar John, Carmont, Sue-Ann, Schluter, Philip J., Good, Phillip, Vora, Rohan and Currow, David (2015). Testing pilocarpine drops for dry mouth in advanced cancer using n-of-1 trials: A feasibility study. Palliative Medicine, 29 (10), 967-974. doi: 10.1177/0269216315585473

Double-blind, placebo-controlled, randomized trial of octreotide in malignant bowel obstruction

Currow, D.C., Quinn, S., Agar, M., Fazekas, B., Hardy, J., McCaffrey, N., Eckermann, S., Abernethy, A.P. and Clark, K. (2015). Double-blind, placebo-controlled, randomized trial of octreotide in malignant bowel obstruction. Journal of Pain and Symptom Management, 49 (5), 814-821. doi: 10.1016/j.jpainsymman.2014.09.013

Pharmacological options for the management of refractory cancer pain—what is the evidence?

Afsharimani, B., Kindl, K., Good, P. and Hardy, J. (2015). Pharmacological options for the management of refractory cancer pain—what is the evidence?. Supportive Care in Cancer, 23 (5), 1473-1481. doi: 10.1007/s00520-015-2678-9

Validation of a fentanyl transdermal adhesion scoring tool for use in clinical practice

Bista, Sudeep Raj, Hardy, Janet, Tapuni, Angela, Fu, Jinlin, Gibbons, Kristen, Good, Phillip, Norris, Ross and Haywood, Alison (2015). Validation of a fentanyl transdermal adhesion scoring tool for use in clinical practice. Journal of Pain and Symptom Management, 49 (5), 934-938. doi: 10.1016/j.jpainsymman.2014.09.017

Corticosteroids for the management of cancer-related pain in adults (Review)

Haywood, Alison, Good, Phillip, Khan, Sohil, Leupp, Aurelia, Jenkins-Marsh, Sue, Rickett, Kirsty and Hardy, Janet R. (2015). Corticosteroids for the management of cancer-related pain in adults (Review). Cochrane Database of Systematic Reviews, 2015 (4) CD010756. doi: 10.1002/14651858.CD010756.pub2

Negotiating futility, managing emotions: nursing the transition to palliative care

Broom, Alex, Kirby, Emma, Good, Phillip, Wootton, Julia, Yates, Patsy and Hardy, Janet (2015). Negotiating futility, managing emotions: nursing the transition to palliative care. Qualitative Health Research, 25 (3), 299-309. doi: 10.1177/1049732314553123

Protein binding of fentanyl and its metabolite nor-fentanyl in human plasma, albumin and α-1 acid glycoprotein

Bista, Sudeep Raj, Haywood, Alison, Hardy, Janet, Lobb, Michael, Tapuni, Angela and Norris, Ross (2015). Protein binding of fentanyl and its metabolite nor-fentanyl in human plasma, albumin and α-1 acid glycoprotein. Xenobiotica, 45 (3), 207-212. doi: 10.3109/00498254.2014.971093

CYP2B6*6 allele and age substantially reduce steady-state ketamine clearance in chronic pain patients: impact on adverse effects

Li, Yibai, Jackson, Kate A., Slon, Barry, Hardy, Janet R., Franco, Michael, William, Leeroy, Poon, Peter, Coller, Janet K, Hutchinson, Mark R, Currow, David C and Somogyi, Andrew A (2015). CYP2B6*6 allele and age substantially reduce steady-state ketamine clearance in chronic pain patients: impact on adverse effects. British Journal of Clinical Pharmacology, 80 (2), 276-284. doi: 10.1111/bcp.12614

Exposure to fentanyl after transdermal patch administration for cancer pain management

Bista, Sudeep R., Haywood, Alison, Hardy, Janet, Norris, Ross and Hennig, Stefanie (2015). Exposure to fentanyl after transdermal patch administration for cancer pain management. Journal of Clinical Pharmacology, 56 (6), 705-713. doi: 10.1002/jcph.641

Therapeutic challenges in cancer pain management: a systematic review of methadone

Good, Phillip, Afsharimani, Banafsheh, Movva, Rayma, Haywood, Alison, Khan, Sohil and Hardy, Janet (2014). Therapeutic challenges in cancer pain management: a systematic review of methadone. Journal of Pain and Palliative Care Pharmacotherapy, 28 (3), 197-205. doi: 10.3109/15360288.2014.938883

Vitamin D deficiency in patients with malignancy in Brisbane

Morton, Adam, Hardy, Janet, Morton, Anthony, Tapuni, Angela, Anderson, Helen, Kingi, Ngaire and Shannon, Catherine (2014). Vitamin D deficiency in patients with malignancy in Brisbane. Supportive Care in Cancer, 22 (8), 2223-2227. doi: 10.1007/s00520-014-2218-z

Development, validation and application of an HPLC-MS/MS method for the determination of fentanyl and nor-fentanyl in human plasma and saliva

Bista, S.R., Lobb, M., Haywood, A., Hardy, J., Tapuni, A. and Norris, R. (2014). Development, validation and application of an HPLC-MS/MS method for the determination of fentanyl and nor-fentanyl in human plasma and saliva. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 960, 27-33. doi: 10.1016/j.jchromb.2014.04.019

Implementing practice change in chronic cancer pain management: clinician response to a phase III study of ketamine

Hardy, J. R., Spruyt, O., Quinn, S. J., Devilee, L. R. and Currow, D. C. (2014). Implementing practice change in chronic cancer pain management: clinician response to a phase III study of ketamine. Internal Medicine Journal, 44 (6), 586-591. doi: 10.1111/imj.12442

A good death in hospital

Hardy, J. R. and Good, P. (2014). A good death in hospital. Internal Medicine Journal, 44 (4), 313-314. doi: 10.1111/imj.12378

Preliminary development and validation of a new end-of-life patient-reported outcome measure assessing the ability of patients to finalise their affairs at the end of life

McCaffrey, Nikki, Skuza, Pawel, Breaden, Katrina, Eckermann, Simon, Hardy, Janet, Oaten, Sheila, Briffa, Michael and Currow, David (2014). Preliminary development and validation of a new end-of-life patient-reported outcome measure assessing the ability of patients to finalise their affairs at the end of life. PLoS One, 9 (4) e94316, e94316. doi: 10.1371/journal.pone.0094316

Should the dosage of controlled-release oxycodone in advanced cancer be modified on the basis of patient characteristics?

Charles, Bruce, Hardy, Janet, Anderson, Helen, Tapuni, Angela, George, Rani and Norris, Ross (2014). Should the dosage of controlled-release oxycodone in advanced cancer be modified on the basis of patient characteristics?. Supportive Care in Cancer, 22 (2), 325-330. doi: 10.1007/s00520-013-1973-6

Do pilocarpine drops help dry mouth in palliative care patients: a protocol for an aggregated series of n-of-1 trials

Nikles, Jane, Mitchell, Geoffrey K., Hardy, Janet, Agar, Meera, Senior, Hugh, Carmont, Sue-Ann, Schluter, Philip J., Good, Phillip, Vora, Rohan and Currow, David (2013). Do pilocarpine drops help dry mouth in palliative care patients: a protocol for an aggregated series of n-of-1 trials. BMC Palliative Care, 12 (39) 39, 1-15. doi: 10.1186/1472-684X-12-39

Corticosteroids for the management of cancer-related pain in adults (Protocol)

Hardy, Janet R., Jenkins-Marsh, Sue, Pinkerton, Eve, Rickett, Kirsty and Good, Phillip (2013). Corticosteroids for the management of cancer-related pain in adults (Protocol). Cochrane Database of Systematic Reviews, 2013 (10) CD010756. doi: 10.1002/14651858.CD010756

Ketamine in the management of cancer pain: reply to K. Jackson et al and W. Leppert

Hardy, Janet, Quinn, Steve, Fazekas, Belinda, Eckermann, Simon, Agar, Meera R., Spruyt, Odette, Rowett, Debra and Currow, David (2013). Ketamine in the management of cancer pain: reply to K. Jackson et al and W. Leppert. Journal of Clinical Oncology, 31 (10), 1375-1376. doi: 10.1200/JCO.2012.47.9469

Can the LANSS scale be used to classify pain in chronic cancer pain trials?

Hardy, Janet, Quinn, Stephen, Fazekas, Belinda, Aga, Meera and Currow, David (2013). Can the LANSS scale be used to classify pain in chronic cancer pain trials?. Supportive Care in Cancer, 21 (12), 3387-3391. doi: 10.1007/s00520-013-1921-5

Placebo and nocebo effects in randomized controlled trials: the implications for research and practice

Sanderson, Christine, Hardy, Janet, Spruyt, Odette and Currow, David C. (2013). Placebo and nocebo effects in randomized controlled trials: the implications for research and practice. Journal of Pain and Symptom Management, 46 (5), 722-730. doi: 10.1016/j.jpainsymman.2012.12.005

Using aggregated single patient (N-of-1) trials to determine the effectiveness of psychostimulants to reduce fatigue in advanced cancer patients: a rationale and protocol

Senior, Hugh E. J., Mitchell, Geoffrey K., Nikles, Jane, Carmont, Sue-Ann, Schluter, Philip J., Currow, David C., Vora, Rohan, Yelland, Michael J., Agar, Meera, Good, Phillip D. and Hardy, Janet R. (2013). Using aggregated single patient (N-of-1) trials to determine the effectiveness of psychostimulants to reduce fatigue in advanced cancer patients: a rationale and protocol. BMC Palliative Care, 12 (1) 17, 17.1-17.6. doi: 10.1186/1472-684X-12-17

Designing and conducting randomized controlled trials in palliative care: a summary of discussions from the 2010 clinical research forum of the Australian Palliative Care Clinical Studies Collaborative

Shelby-James, Tania M., Hardy, Janet, Agar, Meera, Yates, Patsy, Mitchell, Geoff, Sanderson, Christine, Luckett, Tim, Abernethy, Amy P. and Currow, David C. (2012). Designing and conducting randomized controlled trials in palliative care: a summary of discussions from the 2010 clinical research forum of the Australian Palliative Care Clinical Studies Collaborative. Palliative Medicine, 26 (8), 1042-1047. doi: 10.1177/0269216311417036

Randomized, double-blind, placebo-controlled study to assess the efficacy and toxicity of subcutaneous ketamine in the management of cancer pain

Hardy, Janet, Quinn, Stephen, Fazekas, Belinda, Plummer, John, Eckermann, Simon, Agar, Meera, Spruyt, Odette, Rowett, Debra and Currow, David C. (2012). Randomized, double-blind, placebo-controlled study to assess the efficacy and toxicity of subcutaneous ketamine in the management of cancer pain. Journal of Clinical Oncology, 30 (29), 3611-3617. doi: 10.1200/JCO.2012.42.1081

Is saliva a valid substitute for plasma in pharmacokinetic studies of oxycodone and its metabolites in patients with cancer?

Hardy, Janet, Norris, Ross, Anderson, Helen, O'Shea, Angela and Charles, Bruce G. (2012). Is saliva a valid substitute for plasma in pharmacokinetic studies of oxycodone and its metabolites in patients with cancer?. Supportive Care in Cancer, 20 (4), 767-772. doi: 10.1007/s00520-011-1147-3

Defining Refractory Pain in Cancer for Clinicians and Researchers

Currow, David C., Spruyt, Odette and Hardy, Janet (2012). Defining Refractory Pain in Cancer for Clinicians and Researchers. Journal of Palliative Medicine, 15 (1), 5-6. doi: 10.1089/jpm.2011.0326

Progressing an evidence-base beyond case series

Hardy, Janet, Agar, Meera R. and Currow, David C. (2011). Progressing an evidence-base beyond case series. Journal of Palliative Medicine, 14 (12), 1283-1283. doi: 10.1089/jpm.2011.0323

Ectopic adrenocorticotrophic hormone syndrome associated with poor prognosis in metastatic parotid acinic cell carcinoma

Shenoy, Vasant V., Lwin, Zarnie, Morton, Adam and Hardy, Janet (2011). Ectopic adrenocorticotrophic hormone syndrome associated with poor prognosis in metastatic parotid acinic cell carcinoma. Otolaryngology-Head and Neck Surgery, 145 (5), 878-879. doi: 10.1177/0194599811408224

Aggregating single patient (n-of-1) trials in populations where recruitment and retention was difficult: The case of palliative care

Nikles, Jane, Mitchell, Geoffrey K., Schluter, Philip, Good, Phillip, Hardy, Janet, Rowett, Debra, Shelby-James, Tania, Vohra, Sunita and Currow, David (2011). Aggregating single patient (n-of-1) trials in populations where recruitment and retention was difficult: The case of palliative care. Journal of Clinical Epidemiology, 64 (5), 471-480. doi: 10.1016/j.jclinepi.2010.05.009

Is levomepromazine stable over time?

Hardy, J., O'Shea, A., Gilbert, C. and Norris, R. (2011). Is levomepromazine stable over time?. Palliative Medicine, 25 (3), 284-285. doi: 10.1177/0269216310387963

Planning phase III multi-site clinical trials in palliative care: The role of consecutive cohort audits to identify potential participant populations

Currow, D, Shelby-James, T, Agar, M, Plummer, J, Rowett, D, Glare, P, Spruyt, O and Hardy, Janet R. (2010). Planning phase III multi-site clinical trials in palliative care: The role of consecutive cohort audits to identify potential participant populations. Supportive Care in Cancer, 18 (12), 1571-1579. doi: 10.1007/s00520-009-0780-6

Pilot study to determine the optimal dose of methylphenidate for an n-of-1 trial for fatigue in patients with cancer

Hardy, Janet Rea, Carmont, Sue-Ann S., O'Shea, Angela, Vora, Rohan, Schluter, Philip, Nikles, Catherine Jane and Mitchell, Geoffrey Keith (2010). Pilot study to determine the optimal dose of methylphenidate for an n-of-1 trial for fatigue in patients with cancer. Journal of Palliative Medicine, 13 (10), 1193-1197. doi: 10.1089/jpm.2010.0185

Central sleep apnea in cancer patients on opioids

Hardy, Janet R. and Bowler, Simon D. (2010). Central sleep apnea in cancer patients on opioids. Journal of Pain and Symptom Management, 40 (3), e3-e5. doi: 10.1016/j.jpainsymman.2010.06.005

What do palliative care patients and their relatives think about research in palliative care? - a systematic review

White, Clare and Hardy, Janet R. (2010). What do palliative care patients and their relatives think about research in palliative care? - a systematic review. Supportive Care in Cancer, 18 (8), 905-911. doi: 10.1007/s00520-009-0724-1

Role of pharmacogenomics in pain therapy: Focus on opioids

Somogyi, Andrew A. and Hardy, Janet (2010). Role of pharmacogenomics in pain therapy: Focus on opioids. Cancer Forum, 34 (2), 74-76.

The efficacy of haloperidol in the management of nausea and vomiting in patients with cancer

Hardy, Janet R., O'Shea, Angela, White, Clare, Gilshenan, Kristen, Welch, Louise and Douglas, Carol (2010). The efficacy of haloperidol in the management of nausea and vomiting in patients with cancer. Journal of Pain and Symptom Management, 40 (1), 111-116. doi: 10.1016/j.jpainsymman.2009.11.321

Research in palliative care: Is death always an adverse event?

Hardy, J., Shelby-James, T. and Currow, D.C. (2010). Research in palliative care: Is death always an adverse event?. Internal Medicine Journal, 40 (1), 89-90. doi: 10.1111/j.1445-5994.2009.02083.x

Attitudes of patients with advanced cancer toward research

White, Clare and Hardy, Janet (2009). Attitudes of patients with advanced cancer toward research. Journal of Pain and Symptom Management, 38 (5), e5-e6. doi: 10.1016/j.jpainsymman.2009.07.001

Prioritising drugs for single patient (n-of-1) trials in palliative care

Nikles, J., Mitchell, G., Walters, J., Hardy, J., Good, P., Rowett, D., Shelby-James, T. and Currow, D. (2009). Prioritising drugs for single patient (n-of-1) trials in palliative care. Palliative Medicine, 23 (7), 623-634. doi: 10.1177/0269216309106461

Editorial: Balancing patient confidentiality and the needs of carers

White, C. and Hardy, J. (2009). Editorial: Balancing patient confidentiality and the needs of carers. Internal Medicine Journal, 39 (9), 561-562. doi: 10.1111/j.1445-5994.2009.02018.x

Using national health policies to improve access to palliative care medications in the community

Rowett, D., Ravenscroft, P. J., Hardy, Janet R. and Currow, D. C. (2009). Using national health policies to improve access to palliative care medications in the community. Journal of Pain And Symptom Management, 37 (3), 395-402. doi: 10.1016/j.jpainsymman.2008.03.013

Palliative care: core skills and clinical competencies. - by L. L. Emanuel and S. L. Librach

Hardy, J. and Haberecht, J. (2008). Palliative care: core skills and clinical competencies. - by L. L. Emanuel and S. L. Librach. Internal Medicine Journal, 38 (12), 933-933. doi: 10.1111/j.1445-5994.2008.01839.x

Randomised controlled trials of palliative care - a survey of the views of advanced cancer patients and their relatives

White, C., Hardy, J., Gilshenan, K. S., Charles, M. A. and Pinkerton, C. R. (2008). Randomised controlled trials of palliative care - a survey of the views of advanced cancer patients and their relatives. European Journal of Cancer, 44 (13), 1820-1828. doi: 10.1016/j.ejca.2008.05.003

Gatekeeping from palliative care research trials

White, Clare and Hardy, Janet (2008). Gatekeeping from palliative care research trials. Progress in Palliative Care, 16 (4), 167-171. doi: 10.1179/096992608x346189

End-of-life decision-making in intensive care: the case for an international standard or a standard of care?

Townsend, S. C. and Hardy, J. (2008). End-of-life decision-making in intensive care: the case for an international standard or a standard of care?. Journal of Internal Medicine, 38 (5), 303-304. doi: 10.1111/j.1445-5994.2008.01654.x

A survey of the views of palliative care healthcare professionals towards referring cancer patients to participate in randomised controlled trials in palliative care

White, C., Gilshenan, K. and Hardy, J. R. (2008). A survey of the views of palliative care healthcare professionals towards referring cancer patients to participate in randomised controlled trials in palliative care. Supportive Care in Cancer, 16 (12), 1397-1405. doi: 10.1007/s00520-008-0441-1

Barriers to the best care of the dying in Queensland, Australia

Hardy, Janet, Maresco-Pennisi, Diane, Gilshenan, Kristen and Yates, Patsy (2008). Barriers to the best care of the dying in Queensland, Australia. Journal of Palliative Medicine, 11 (10), 1325-1329. doi: 10.1089/jpm.2008.0170

Gatekeeping from palliative care research trials

White, C. and Hardy, J. R. (2008). Gatekeeping from palliative care research trials. Progress in Palliative Care, 16 (4), 167-172.

Subcutaneous sufentanil for palliative care patients in a hospital setting

White, C., Hardy, J., Boyd, A. and Hall, A. (2008). Subcutaneous sufentanil for palliative care patients in a hospital setting. Palliative Medicine, 22 (1), 89-90. doi: 10.1177/0269216307085177

Treatment of nausea and vomiting in terminally ill cancer patients

Glare, P. A., Dunwoodie, D., Clark, K., Ward, A., Yates, P., Ryan, S. and Hardy, J. R. (2008). Treatment of nausea and vomiting in terminally ill cancer patients. Drugs, 68 (18), 2575-2590. doi: 10.2165/0003495-200868180-00004

Author's response

Hardy, Janet R., Herbert, Anthony R. and Reymond, Elizabeth (2007). Author's response. Journal of Pain and Symptom Management, 34 (1), 6-6. doi: 10.1016/j.jpainsymman.2007.04.002

Audit of the care of the dying in a network of hospitals and institutions in Queensland

Hardy, Janet R., Haberecht, J., Maresco-Pennisi, D. and Yates, P. (2007). Audit of the care of the dying in a network of hospitals and institutions in Queensland. Internal Medicine Journal, 37 (5), 315-319. doi: 10.1111/j.1445-5994.2007.01314.x

Quality use of medicines for palliative care

Hardy, J. R. (2007). Quality use of medicines for palliative care. Cancer Forum, 31 (1), 9-11.

Clinical Practice Guidelines for communicating prognosis and end-of-life issues with adults in the advanced stages of a life-limiting illness, and their caregivers

Clayton, J., Hancock, M., Butow, P., Tattersall, M., Currow, D., Australian and New Zealand Expert Advisory Group, Hardy, Janet and Mitchell, G. (2007). Clinical Practice Guidelines for communicating prognosis and end-of-life issues with adults in the advanced stages of a life-limiting illness, and their caregivers. Medical Journal of Australia, 186 (12; Suppl.), S77-S83. doi: 10.5694/j.1326-5377.2007.tb01100.x

Opioids in patients on renal dialysis

Hardy, Janet R., Herbert, Anthony R. and Reymond, Elizabeth (2007). Opioids in patients on renal dialysis. Journal of Pain and Symptom Management, 33 (1), 1-2. doi: 10.1016/j.jpainsymman.2006.09.003

Consent for investigating and treating adults with cancer

Tait, D. M. and Hardy, J. (2006). Consent for investigating and treating adults with cancer. Clinical Oncology, 18 (1), 23-29. doi: 10.1016/j.clon.2005.08.016

Developing guidelines for syringe driver management

Kain, V., Yates, P., Barret, L., Bradley, T., Circosta, M., Hall, A. and Hardy, J. (2006). Developing guidelines for syringe driver management. International Journal of Palliative Nursing, 12 (2), 60-69. doi: 10.12968/ijpn.2006.12.2.20532

Gabapentin is effective in the treatment of cancer-related neuropathic pain: A prospective, open-label study

Ross, J.R., Goller, K., Hardy, J., Riley, J., Broadley, K., A'hern, R. and Williams, J. (2005). Gabapentin is effective in the treatment of cancer-related neuropathic pain: A prospective, open-label study. Journal of Palliative Medicine, 8 (6), 1118-1126. doi: 10.1089/jpm.2005.8.1118

Experience in the use of the palliative care outcome scale

Stevens, A.-M, Gwilliam, B., A'Hern, R., Broadley, K. and Hardy, J. (2005). Experience in the use of the palliative care outcome scale. Supportive Care In Cancer, 13 (12), 1027-1034. doi: 10.1007/s00520-005-0815-6

Creating a palliative care research network in Queensland, Australia: Is this the answer?

Hardy, J., Dingle, K., Beebe, H. and Yates, P. (2005). Creating a palliative care research network in Queensland, Australia: Is this the answer?. Progress in Palliative Care, 13 (5), 277-281. doi: 10.1179/096992605X75903

An open study of methotrimeprazine in the management of nausea and vomiting in patients with advanced cancer

Kennett, A., Hardy, J., Shah, S. and Hern, R.A. (2005). An open study of methotrimeprazine in the management of nausea and vomiting in patients with advanced cancer. Supportive Care in Cancer, 13 (5), 715-721. doi: 10.1007/s00520-004-0768-1

Acetaminophen in cancer pain

Hardy, Janet, Reymond, Elizabeth and Charles, Margaret (2005). Acetaminophen in cancer pain. Journal of Clinical Oncology, 23 (7), 1586-1586. doi: 10.1200/JCO.2005.05.239

Approval by MREC of a modified patient information and consent form: Does this set a precedent for trials in palliative care?

Dentith, J. R. and Hardy, J. R. (2004). Approval by MREC of a modified patient information and consent form: Does this set a precedent for trials in palliative care?. Palliative Medicine, 18 (5), 484-485. doi: 10.1191/0269216304pm909xx

A good death down under

Hardy, J. R. and Vora, R. (2004). A good death down under. Internal Medicine Journal, 34 (8), 450-452. doi: 10.1111/j.1444-0903.2004.00665.x

Issues in research in palliative care

Hardy, J. (2004). Issues in research in palliative care. Centre On-Line

Evidence-based complementary medicine for palliative cancer care: does it make sense?

Ernst, E., Filshie, J. and Hardy, Janet (2003). Evidence-based complementary medicine for palliative cancer care: does it make sense?. Palliative Medicine, 17 (8), 704-707. doi: 10.1191/0269216303pm816oa

Handbook of advanced cancer care

Hardy, Janet (2003). Handbook of advanced cancer care. Journal of the Royal Society of Medicine, 96 (12), 616-616. doi: 10.1258/jrsm.96.12.616

A survey of insurance cover for research in independent hospice

Lucas, Caroline and Hardy, Janet (2003). A survey of insurance cover for research in independent hospice. Palliative Medicine, 17 (7), 648-649. doi: 10.1177/026921630301700718

Novel consent process for research in dying patients unable to give consent

Rees, Elizabeth and Hardy, Janet (2003). Novel consent process for research in dying patients unable to give consent. British Medical Journal, 327 (7408), 198-201. doi: 10.1136/bmj.327.7408.198

Care of the dying woman with breast cancer

Hardy, J. (2003). Care of the dying woman with breast cancer. Trends in Urology, Gynaecology and Sexual Health, 8 (4), 24-26.

Symptom control in women with advanced breast cancer

Hardy, J. (2003). Symptom control in women with advanced breast cancer. Trends in Urology, Gynaecology and Sexual Health, 8 (3), 19-26.

The treatment of hiccups in terminal patients

Hardy, Janet (2003). The treatment of hiccups in terminal patients. European Journal of Palliative Care, 10 (5), 192-193.

A double-blind, randomised, parallel group, multinational, multicentre study comparing a single dosed of ondansetron 24 mg p.o. with placebo and metoclopramide 10 mg t.d.s. p.o. in the treatment of opioid-induced nausea and emesis in cancer patients

Hardy, J, Daly, S, McQuade, B, Albertsson, M, Chimontsi-Kypriou, V, Stathopoulos, GP and Curtis, P (2002). A double-blind, randomised, parallel group, multinational, multicentre study comparing a single dosed of ondansetron 24 mg p.o. with placebo and metoclopramide 10 mg t.d.s. p.o. in the treatment of opioid-induced nausea and emesis in cancer patients. Supportive Care in Cancer, 10 (3), 231-236. doi: 10.1007/s00520-001-0332-1

Is there a dose response relationship for clodronate in the treatment of tumour induced hypercalcaemia?

Shah, S., Hardy, J., Rees, E., Ling, J., Gwilliam, B., Davis, C., Broadley, K. and A'Hern, R. (2002). Is there a dose response relationship for clodronate in the treatment of tumour induced hypercalcaemia?. British Journal of Cancer, 86 (8), 1235-1237. doi: 10.1038/sj.bjc.6600249

Fatigue in patients with cancers of the breast or prostate undergoing radical radiotherapy

Stone, Patrick, Richards, Michael, A'Hern, Roger and Hardy, Janet (2001). Fatigue in patients with cancers of the breast or prostate undergoing radical radiotherapy. Journal of Pain and Symptom Management, 22 (6), 1007-1015. doi: 10.1016/S0885-3924(01)00361-X

Randomized, double-blind, placebo-controlled, multicenter trial of 6% miltefosine solution, a topical chemotherapy in cutaneous metastases from breast cancer

Leonard, R, Hardy, J, van Tienhoven, G, Houston, S, Simmonds, P, David, M and Mansi, J (2001). Randomized, double-blind, placebo-controlled, multicenter trial of 6% miltefosine solution, a topical chemotherapy in cutaneous metastases from breast cancer. Journal of Clinical Oncology, 19 (21), 4150-4159. doi: 10.1200/JCO.2001.19.21.4150

End of life care in patients with malignant disease

Stone, P, Rees, E and Hardy, JR (2001). End of life care in patients with malignant disease. European Journal of Cancer, 37 (9), 1070-1075. doi: 10.1016/S0959-8049(01)00087-9

SOR: project methodology

Fervers, B., Hardy, J., Blanc-Vincent, M. P., Theobald, S., Bataillard, A., Farsi, F., Gory, G., Debuiche, S., Guillo, S., Renaud-Salis, J. L., Pinkerton, R., Bey, P. and Philip, T. (2001). SOR: project methodology. British Journal of Cancer, 84 (s2), 8-16. doi: 10.1054/bjoc.2000.1757

A phase II study to establish the efficacy and toxicity of sodium valproate in patients with cancer-related neuropathic pain

Hardy, JR, Rees, EAJ, Gwilliam, B, Ling, J, Broadley, K and A'Hern, R (2001). A phase II study to establish the efficacy and toxicity of sodium valproate in patients with cancer-related neuropathic pain. Journal of Pain and Symptom Management, 21 (3), 204-209. doi: 10.1016/S0885-3924(00)00266-9

A Review of the COX-2 Inhibitors

Shah, Shamsul and Hardy, Janet (2001). A Review of the COX-2 Inhibitors. Progress in Palliative Care, 9 (2), 47-52. doi: 10.1080/09699260.2001.11746904

A prospective survey of the use of dexamethasone on a palliative care unit

Hardy, JR, Rees, E, Ling, J, Burman, R, Feuer, D, Broadley, K and Stone, P (2001). A prospective survey of the use of dexamethasone on a palliative care unit. Palliative Medicine, 15 (1), 3-8. doi: 10.1191/026921601673324846

Consent for trials in palliative care

Hardy, J (2000). Consent for trials in palliative care. Lancet, 356 (9248), S44-S44. doi: 10.1016/S0140-6736(00)92030-0

Sedation in terminally ill patients

Hardy, J (2000). Sedation in terminally ill patients. Lancet, 356 (9245), 1866-1867. doi: 10.1016/S0140-6736(00)03252-9

Fatigue in patients with prostate cancer receiving hormone therapy

Stone, P, Hardy, J, Huddart, R, A'Hern, R and Richards, M (2000). Fatigue in patients with prostate cancer receiving hormone therapy. European Journal of Cancer, 36 (9), 1134-1141. doi: 10.1016/S0959-8049(00)00084-8

A study to investigate the prevalence, severity and correlates of fatigue among patients with cancer in comparison with a control group of volunteers without cancer

Stone, P, Richards, M, A'Hern, R and Hardy, J (2000). A study to investigate the prevalence, severity and correlates of fatigue among patients with cancer in comparison with a control group of volunteers without cancer. Annals of Oncology, 11 (5), 561-567. doi: 10.1023/A:1008331230608

Outcome of malignant spinal cord compression at a cancer center: Implications for palliative care services

Cowap, J, Hardy, JR and A'Hern, R (2000). Outcome of malignant spinal cord compression at a cancer center: Implications for palliative care services. Journal of Pain and Symptom Management, 19 (4), 257-264. doi: 10.1016/S0885-3924(00)00110-X

What influences participation in clinical trials in palliative care in a cancer centre?

Ling, J, Rees, E and Hardy, J (2000). What influences participation in clinical trials in palliative care in a cancer centre?. European Journal of Cancer, 36 (5), 621-626. doi: 10.1016/S0959-8049(99)00330-5

The use of the Rotterdam symptom checklist in palliative care

Hardy, JR, Edmonds, P, Turner, R, Rees, E and A'Hern, R (1999). The use of the Rotterdam symptom checklist in palliative care. Journal of Pain and Symptom Management, 18 (2), 79-84. doi: 10.1016/S0885-3924(99)00050-0

Fatigue in advanced cancer: a prospective controlled cross-sectional study

Stone, P., Hardy, J., Broadley, K., Tookman, A. J., Kurowska, A. and A'Hern, R. (1999). Fatigue in advanced cancer: a prospective controlled cross-sectional study. British Journal of Cancer, 79 (9-10), 1479-1486. doi: 10.1038/sj.bjc.6690236

Pitfalls in placebo-controlled trials in palliative care: dexamethasone for the palliation of malignant bowel obstruction

Hardy, J, Ling, J, Mansi, J, Isaacs, R, A'Hern, R, Blake, P, Gore, M, Shepherd, J and Hanks, G (1998). Pitfalls in placebo-controlled trials in palliative care: dexamethasone for the palliation of malignant bowel obstruction. Palliative Medicine, 12 (6), 437-442. doi: 10.1191/026921698666334766

Fatigue in patients with cancer

Stone, P, Richards, M and Hardy, J (1998). Fatigue in patients with cancer. European Journal of Cancer, 34 (11), 1670-1676. doi: 10.1016/S0959-8049(98)00167-1

Thioridazine in the management of cancer-related sweating

Cowap, J and Hardy, J (1998). Thioridazine in the management of cancer-related sweating. Journal of Pain and Symptom Management, 15 (5), 266-266.

A survey of transdermal fentanyl use in a major cancer center

Hardy, JR (1998). A survey of transdermal fentanyl use in a major cancer center. Journal of Pain and Symptom Management, 15 (4), 213-214.

The use of the Edmonton Symptom Assessment Scale (ESAS) within a palliative care unit in the UK

Rees, E, Hardy, J, Ling, J, Broadley, K and A'Hern, R (1998). The use of the Edmonton Symptom Assessment Scale (ESAS) within a palliative care unit in the UK. Palliative Medicine, 12 (2), 75-82. doi: 10.1191/026921698674135173

Placebo-controlled trials in palliative care: the argument for

Hardy, JR (1997). Placebo-controlled trials in palliative care: the argument for. Palliative Medicine, 11 (5), 415-418. doi: 10.1177/026921639701100514

Palliative medicine in cancer

Stone, Patrick and Hardy, Janet (1997). Palliative medicine in cancer. The Lancet, 350 (9073), 296. doi: 10.1016/s0140-6736(05)62270-2

Can transdermal fentanyl cause diarrhea?

Hardy, Janet R. (1997). Can transdermal fentanyl cause diarrhea?. Journal of Pain and Symptom Management, 13 (4), 188-189. doi: 10.1016/s0885-3924(97)00037-7

Analysis of survival following treatment of tumour-induced hypercalcaemia with intravenous pamidronate (APD)

Ling, P. J., Ahern, R. P. and Hardy, J. R. (1995). Analysis of survival following treatment of tumour-induced hypercalcaemia with intravenous pamidronate (APD). British Journal of Cancer, 72 (1), 206-209. doi: 10.1038/bjc.1995.304

Symptom relief with MVP (mitomycin C, vinblastine and cisplatin) chemotherapy in advanced non-small-cell lung cancer

Ellis, P. A., Smith, I. E., Hardy, J. R., Nicolson, M. C., Talbot, D. C., Ashley, S. E. and Priest, K. (1995). Symptom relief with MVP (mitomycin C, vinblastine and cisplatin) chemotherapy in advanced non-small-cell lung cancer. British Journal of Cancer, 71 (2), 366-370. doi: 10.1038/bjc.1995.74

Subcutaneous Ketorolac

Duncan, AR, Hardy, JR and Davis, CL (1995). Subcutaneous Ketorolac. Palliative Medicine, 9 (1), 77-78. doi: 10.1177/026921639500900111

Current issues in cancer palliative care

Davis, C. L. and Hardy, J. R. (1994). Current issues in cancer palliative care. BMJ, 308 (6940), 1359-1362. doi: 10.1136/bmj.308.6940.1359

An audit of morphine prescribing in a specialist cancer hospital

Turner, Rose, Clark, Judith, Root, Timothy and Hardy, Janet (1994). An audit of morphine prescribing in a specialist cancer hospital. Palliative Medicine, 8 (1), 5-10. doi: 10.1177/026921639400800102

Prediction of Survival in a Hospital-Based Continuing Care Unit

Hardy, JR, Turner, R, Saunders, M and Ahern, R (1994). Prediction of Survival in a Hospital-Based Continuing Care Unit. European Journal of Cancer, 30A (3), 284-288. doi: 10.1016/0959-8049(94)90242-9

A Phase-Ii Study of Sulofenur, a Novel Sulfonylurea, in Recurrent Epithelial Ovarian-Cancer

Obrien, Mer, Hardy, J, Tan, S, Walling, J, Peters, B, Hatty, S and Wiltshaw, E (1992). A Phase-Ii Study of Sulofenur, a Novel Sulfonylurea, in Recurrent Epithelial Ovarian-Cancer. Cancer Chemotherapy and Pharmacology, 30 (3), 245-248. doi: 10.1007/BF00686324

Phase II Study of the Amsacrine Analog Ci-921 (nsc 343499) in Non-Small-Cell Lung-Cancer

Harvey, VJ, Hardy, JR, Smith, S, Grove, W and Baguley, BC (1991). Phase II Study of the Amsacrine Analog Ci-921 (nsc 343499) in Non-Small-Cell Lung-Cancer. European Journal of Cancer, 27 (12), 1617-1620. doi: 10.1016/0277-5379(91)90427-F

Hypoprothrombinemia From Coadministration of Sulofenur (ly-186641) and Warfarin - Report of 3 Cases

Fossella, FV, Lippman, SM, Seitz, DE, Alberts, DS, Taylor, CW, Wiltshaw, E, Hardy, J, Obrien, M, Haynes, TR and Wolen, RL (1991). Hypoprothrombinemia From Coadministration of Sulofenur (ly-186641) and Warfarin - Report of 3 Cases. Investigational New Drugs, 9 (4), 357-359.

Lymphedema - Prevention Rather Than Cure

Hardy, JR (1991). Lymphedema - Prevention Rather Than Cure. Annals of Oncology, 2 (8), 532-533. doi: 10.1093/oxfordjournals.annonc.a058015

A randomised trial comparing combination chemotherapy using mitomycin C, mitozantrone and methotrexate (3M) with vincristine, anthracycline and cyclophosphamide (VAC) in advanced breast cancer

Powles, T. J., Jones, A. L., Judson, I. R., Hardy, J. R. and Ashley, S. E. (1991). A randomised trial comparing combination chemotherapy using mitomycin C, mitozantrone and methotrexate (3M) with vincristine, anthracycline and cyclophosphamide (VAC) in advanced breast cancer. British Journal of Cancer, 64 (2), 406-410. doi: 10.1038/bjc.1991.318

The Pharmacokinetics of Oral Lonidamine in Breast and Lung-Cancer Patients

Newell, DR, Mansi, J, Hardy, J, Button, D, Jenns, K, Smith, IE, Picollo, R and Catanese, B (1991). The Pharmacokinetics of Oral Lonidamine in Breast and Lung-Cancer Patients. Seminars in Oncology, 18 (2), 11-17.

Cisplatin and Carboplatin in Combination for the Treatment of Stage-Iv Ovarian-Carcinoma

Hardy, JR, Wiltshaw, E, Blake, PR, Harper, P, Slevin, M, Perren, TJ and Tan, S (1991). Cisplatin and Carboplatin in Combination for the Treatment of Stage-Iv Ovarian-Carcinoma. Annals of Oncology, 2 (2), 131-136. doi: 10.1093/oxfordjournals.annonc.a057876

Clinical-Study and Pharmacokinetics of Lonidamine in Advanced Non-Small Cell Lung-Cancer

Jones, AL, Hardy, JR, Newell, DR and Smith, IE (1991). Clinical-Study and Pharmacokinetics of Lonidamine in Advanced Non-Small Cell Lung-Cancer. European Journal of Cancer, 27 (4), 519-519. doi: 10.1016/0277-5379(91)90403-Z

Magnetic resonance imaging in the detection of skeletal metastases in patients with breast cancer

Jones, A. L., Williams, M. P., Powles, T. J., Oliff, J. F. C., Hardy, J. R., Cherryman, G. and Husband, J. (1990). Magnetic resonance imaging in the detection of skeletal metastases in patients with breast cancer. British Journal of Cancer, 62 (2), 296-298. doi: 10.1038/bjc.1990.281

Carboplatin Dose Optimization

Pinkerton, C. R. and Hardy, J. R. (1990). Carboplatin Dose Optimization. Journal of Clinical Oncology, 8 (7), 1283-1284. doi: 10.1200/JCO.1990.8.7.1283

How nephrotoxic is carboplatin?

Hardy, J. R., Tan, S., Fryatt, I. and Wiltshaw, E. (1990). How nephrotoxic is carboplatin?. British Journal of Cancer, 61 (4), 644-644. doi: 10.1038/bjc.1990.143

Combination of Tamoxifen, Aminoglutethimide, Danazol and Medroxyprogesterone Acetate in Advanced Breast-Cancer

Hardy, JR, Powles, TJ, Judson, IR, Sinnett, HD, Ashley, SE, Coombes, RC and Ellin, CL (1990). Combination of Tamoxifen, Aminoglutethimide, Danazol and Medroxyprogesterone Acetate in Advanced Breast-Cancer. European Journal of Cancer, 26 (7), 824-827. doi: 10.1016/0277-5379(90)90162-M

Case-Report - Magnetic-Resonance Imaging of Spinal Amyloid

Olliff, Jfc, Hardy, JR, Williams, MP and Powles, TJ (1989). Case-Report - Magnetic-Resonance Imaging of Spinal Amyloid. Clinical Radiology, 40 (6), 632-633. doi: 10.1016/S0009-9260(89)80329-0

Symptom relief with moderate dose chemotherapy (mitomycin-C, vinblastine and cisplatin) in advanced non-small cell lung cancer

Hardy, J. R., Noble, T. and Smith, I. E. (1989). Symptom relief with moderate dose chemotherapy (mitomycin-C, vinblastine and cisplatin) in advanced non-small cell lung cancer. British Journal of Cancer, 60 (5), 764-766. doi: 10.1038/bjc.1989.355

Chemoprevention of Breast-Cancer

Powles, TJ, Hardy, JR, Ashley, SE, Cosgrove, D, Davey, JB, Dowsett, M, McKinna, A, Nash, AG, Rundle, SK, Sinnett, HD, Tillyer, CR and Treleaven, JG (1989). Chemoprevention of Breast-Cancer. Breast Cancer Research and Treatment, 14 (1), 23-31. doi: 10.1007/BF01805972

A pilot trial to evaluate the acute toxicity and feasibility of tamoxifen for prevention of breast cancer

Powles, T. J., Hardy, J. R., Ashley, S. E., Farrington, G. M., Cosgrove, D., Davey, J. B., Dowsett, M., McKinna, J. A., Nash, A. G., Sinnett, H. D., Tillyer, C. R. and Treleaven, J. G. (1989). A pilot trial to evaluate the acute toxicity and feasibility of tamoxifen for prevention of breast cancer. British Journal of Cancer, 60 (1), 126-131. doi: 10.1038/bjc.1989.235

Cerebral Metastases in Patients with Ovarian-Cancer Treated with Chemotherapy

Hardy, JR and Harvey, VJ (1989). Cerebral Metastases in Patients with Ovarian-Cancer Treated with Chemotherapy. Gynecologic Oncology, 33 (3), 296-300. doi: 10.1016/0090-8258(89)90515-5

The Effect of Cimetidine, Phenobarbitone and Buthionine Sulfoximine On the Disposition of N-5-Dimethyl-9-[(2-Methoxy-4-Methyl-Sulphonylamino) Phenylamino]-4-Acridinecarboxamide (ci-921) in the Rabbit

Paxton, JW, Evans, PC and Hardy, JR (1989). The Effect of Cimetidine, Phenobarbitone and Buthionine Sulfoximine On the Disposition of N-5-Dimethyl-9-[(2-Methoxy-4-Methyl-Sulphonylamino) Phenylamino]-4-Acridinecarboxamide (ci-921) in the Rabbit. Cancer Chemotherapy and Pharmacology, 23 (5), 291-295. doi: 10.1007/BF00292406

Phase-I Trial of the Amsacrine Analog 9-((2-Methoxy-4-[(methylsulfonyl)amino]-Phenyl(amino)-N,5-Dimethyl-4-Acridinecarboxamide (ci-921)

Hardy, JR, Harvey, VJ, Paxton, JW, Evans, P, Smith, S, Grove, W, Grillolopez, AJ and Baguley, BC (1988). Phase-I Trial of the Amsacrine Analog 9-((2-Methoxy-4-[(methylsulfonyl)amino]-Phenyl(amino)-N,5-Dimethyl-4-Acridinecarboxamide (ci-921). Cancer Research, 48 (22), 6593-6596.

The Clinical Pharmacokinetics of N-5-Dimethyl-9-[(2-Methoxy-4-Methyl-Sulfonylamino)phenylamino]-4-Acridinecarboxamide (ci-921) in a Phase-1 Trial

Paxton, JW, Hardy, JR, Evans, PC, Harvey, VJ and Baguley, BC (1988). The Clinical Pharmacokinetics of N-5-Dimethyl-9-[(2-Methoxy-4-Methyl-Sulfonylamino)phenylamino]-4-Acridinecarboxamide (ci-921) in a Phase-1 Trial. Cancer Chemotherapy and Pharmacology, 22 (3), 235-240. doi: 10.1007/BF00273417

The Treatment of Advanced Recurrent Carcinoma of the Uterine Cervix with Platinum Based Cytotoxic Chemotherapy

Hardy, JR, Maclean, GD, Foote, GA and Harvey, VJ (1987). The Treatment of Advanced Recurrent Carcinoma of the Uterine Cervix with Platinum Based Cytotoxic Chemotherapy. Australian & New Zealand Journal of Obstetrics & Gynaecology, 27 (2), 146-149. doi: 10.1111/j.1479-828X.1987.tb00967.x

'What price do you put on your health?' Medicinal Cannabis, financial toxicity, and patient perspectives on medication access in advanced cancer

Olson, Rebecca, Smith, Alexandra, Good, Phillip, Dudley, Morgan and Hardy, Janet (2022). 'What price do you put on your health?' Medicinal Cannabis, financial toxicity, and patient perspectives on medication access in advanced cancer. The Australian Sociological Association (TASA) conference, Melbourne, VIC Australia, 29 November-2 December 2022.

"What price do you put on your health?": Medical cannabis, financial toxicity, and patient perspectives on medication access in advanced cancer

Olson, Rebecca, Smith, Alexandra, Good, Phillip, Dudley, Morgan and Hardy, Janet (2022). "What price do you put on your health?": Medical cannabis, financial toxicity, and patient perspectives on medication access in advanced cancer. The Australian Sociological Association Conference, Melbourne, VIC, Australia, 28 November - 2 December 2022.

Phase III randomised double-blind controlled trial of oral risperidone, haloperidol or placebo with rescue subcutaneous midazolam for delirium management in palliative care

Agar, Meera, Lawlor, Peter, Quinn, Steve, Caplan, Gideon, Draper, Brian, Rowett, Debra, Devilee, Linda, Fazekas, Belinda, Sanderson, Christine, McCaffery, Nicola, Hardy, Janet, Le, Brian, Eckermann, Simon, Hill, Mark and Currow, David (2015). Phase III randomised double-blind controlled trial of oral risperidone, haloperidol or placebo with rescue subcutaneous midazolam for delirium management in palliative care. Annual Scientific Meeting of the American-Geriatrics-Society (AGS), National Harbor Md, May 10-17, 2015. HOBOKEN: WILEY-BLACKWELL.

Phase III randomized double-blind controlled trial of oral risperidone, haloperidol or placebo with rescue subcutaneous midazolam for delirium management in palliative care

Agar, M., Lawlor, P., Quinn, S., Caplan, G., Draper, B., Rowett, D., Devilee, L., Fazekas, B., Sanderson, C., McCaffrey, N., Hardy, J., Le, B., Eckermann, S., Hill, M. and Currow, D. (2015). Phase III randomized double-blind controlled trial of oral risperidone, haloperidol or placebo with rescue subcutaneous midazolam for delirium management in palliative care. Annual Scientific Meeting of the American-Geriatrics-Society (AGS), National Harbor, MD United States, May 10-17, 2015. Hoboken, NJ United States: Wiley-Blackwell .

Implementing a protocol for vitamin D screening and replacement in cancer patients

Xu, Wen, Hardy, Janet, Lwin, Zarnie, Woodward, Natasha and Shannon, Catherine (2014). Implementing a protocol for vitamin D screening and replacement in cancer patients. Clinical Oncology Society of Australia Annual Scientific Meeting, Melbourne, VIC, Australia, 2-4 December 2014. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/ajco.12305

Implementing a protocol for vitamin-D screening and replacement in cancer patients

Xu, Wen, Hardy, Janet, Lwin, Zarnie, Woodward, Natasha and Shannon, Catherine (2014). Implementing a protocol for vitamin-D screening and replacement in cancer patients. COSA's 41st Annual Scientific Meeting. Joining Forces ‐ Accelerating Progress, Melbourne, VIC Australia, 2‐4 December 2014. Chichester, West Sussex United Kingdom: Wiley-Blackwell.

Overview of N-of-1 study suite – lessons learned from three aggregated N-of-1 trials

Mitchell, Geoff, Nikles, Jane, Carmont, Sue-Ann, Hardy, Janet, Good, Phillip, Agar, Meera, Clark, Katherine, Douglas, Carol, Vora, Rohan, Currow, David and Senior, H. (2013). Overview of N-of-1 study suite – lessons learned from three aggregated N-of-1 trials. PaCCSC 4th Annual Scientific Meeting and Research Forum 2013, Sydney, NSW, Australia, 20-21 Mar, 2013.

A randomized, double-blind, placebo-controlled study to assess the efficacy and toxicity of subcutaneous ketamine in the management of cancer pain

Currow, David C., Hardy, Janet, Quinn, Stephen, Fazekas, Belinda, Plummer, John, Eckermann, Simon, Agar, Meera, Spruyt, Odette and Debra, Rowett (2012). A randomized, double-blind, placebo-controlled study to assess the efficacy and toxicity of subcutaneous ketamine in the management of cancer pain. 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago Il, Jun 01-06, 2012. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY.

The effectiveness of methylphenidate in fatigue in advanced cancer: Aggregated n-of-1 trial results

Mitchell, G., Hardy, J., Carmont, S., Nikles, J., Senior, H., Schluter, P., Good, P., Agar, M., Clark, K., Vora, R. and Currow, D. (2012). The effectiveness of methylphenidate in fatigue in advanced cancer: Aggregated n-of-1 trial results. Australian and New Zealand Society of Palliative Medicine conference, Queenstown, New Zealand, 4 - 7 September 2012.

The effectiveness of methylphenidate in fatigue in advanced cancer: aggregated N-of-1 trails

Mitchell, Geoffrey, Hardy, Janet, Carmont, Sue-Ann, Nikles, Jane, Senior, Hugh, Schluter, Philip, Good, Philip, Agar, Meera, Clark, Katherine, Vora,Rohan, Douglas, Carol and Currow, David (2012). The effectiveness of methylphenidate in fatigue in advanced cancer: aggregated N-of-1 trails. Ipswich Hospital Research Day, Ipswich, Qld, Australia, 1 September 2012.

A Randomised, Double-blind, Placebo Controlled, Multi-site Study of Subcutaneous Ketamine in the Management of Cancer Pain

Currow, D. C., Hardy, J., Agar, M., Sanderson, C., Spruyt, O., Eckermann, S., Plummer, J. and Quinn, S. (2011). A Randomised, Double-blind, Placebo Controlled, Multi-site Study of Subcutaneous Ketamine in the Management of Cancer Pain. European Multidisciplinary Cancer Congress on Integrating Basic and Translational Science, Surgery, Radiotherapy, Medical oncology, Advocacy and Care, Stockholm Sweden, Sep 23-27, 2011. OXFORD: ELSEVIER SCI LTD.

Investigating n-of-1 trials as a means of gathering palliative care evidence

Carmont, S., Currow, D., Hardy, J., Mitchell, G. K., Nikles, J., Schluter, P., Vora, R. and Yelland, M. (2008). Investigating n-of-1 trials as a means of gathering palliative care evidence. 8th Biennial Conference of the Australian and New Zealand Society of Palliative Medicine (ANZSPM), Darwin, NT, Australia, 23-26 September 2008.

Investigating the role of single patient trial as a means of gathering population level evidence in palliative care

Mitchell, G., Nikles, J., Hardy, J., Currow, D., Good, P., Rowett, D. and Walters, J. (2007). Investigating the role of single patient trial as a means of gathering population level evidence in palliative care. Clinical Oncological Society of Australia 34th Annual Scientific Meeting, Adelaide, Australia, 14-16 November, 2007. Carlton, Australia: Blackwell Publishing. doi: 10.1111/j.1743-7563.2007.00127.x

NEED NEPHROTOXICITY LIMIT DOSE INTENSITY STRATEGIES IN OVARIAN-CANCER

HARDY, J, TAN, S, FRYATT, and WILTSHAW, E (1990). NEED NEPHROTOXICITY LIMIT DOSE INTENSITY STRATEGIES IN OVARIAN-CANCER. BASINGSTOKE: STOCKTON PRESS.

Chemotherapy of advanced breast-cancer using Mitomycin-X, Mitoxantrone and Methotrexate (3m) or Vincristine, Anthracycline and Cyclophosphamide (vac)

Jones, A. L., Powles, T. J., Judson, I. R., Hardy, J. R. and Ashley, S. E. (1990). Chemotherapy of advanced breast-cancer using Mitomycin-X, Mitoxantrone and Methotrexate (3m) or Vincristine, Anthracycline and Cyclophosphamide (vac). 31st annual meeting of the British Association of Cancer Research and the 5th annual meeting of the Association of Cancer Physicians, Sussex, United Kingdom, 19-22 March 1990. BASINGSTOKE: STOCKTON PRESS. doi: 10.1038/bjc.1990.324

Dose intensity in ovarian-cancer

Hardy, J. R., Hryniuk, W. M. and Wiltshaw, E. (1990). Dose intensity in ovarian-cancer. 31st Annual Meeting of the British Association of Cancer Research and the 5th Annual Meeting of the Association of Cancer Physicians, Sussex, United Kingdom, 19-22 March 1990. London, United Kingdom: Nature Publishing Group. doi: 10.1038/bjc.1990.324

The Kinetics of 9-[[2-Methoxy-4[(methyl-Sulphonyl)amino]phenyl] Amino]-N, 5-Dimethyl-4-Acridinecarboxamide (ci-921) in a Phase-Ii Study

Evans, PC, Hardy, JR, Paxton, JW, Harvey, VJ and Baguley, BC (1989). The Kinetics of 9-[[2-Methoxy-4[(methyl-Sulphonyl)amino]phenyl] Amino]-N, 5-Dimethyl-4-Acridinecarboxamide (ci-921) in a Phase-Ii Study. WELLINGTON: NEW ZEALAND MED ASSN.

Lack of Diurnal-Variation in Plasma-Levels of Androstenedione, Testosterone, Estrone and Estradiol in Postmenopausal Women

Lonning, PE, Dowsett, M, Jacobs, S, Schem, B, Hardy, J and Powles, TJ (1989). Lack of Diurnal-Variation in Plasma-Levels of Androstenedione, Testosterone, Estrone and Estradiol in Postmenopausal Women. 9th International Symp of the Journal of Steroid Biochemistry : Recent Advances in Steroid Biochemistry, Las Palmas Gran Canaria Spain, May 28-31, 1989. doi: 10.1016/0022-4731(89)90143-X

Review of the Quality of Complementary Medicines Information Resources: Summary Report

McGuire, Treasure, Walters, J.A., Dean, A.J., Van Driel, M., Del Mar, C., Kotsirilos, V., Moses, G.M., Chong, S., Deed, G., Eldred, B., Hardy, J., Heussler, H., Hollingworth, S., Marron, L., Mendel, J. and Pache, D. (2009). Review of the Quality of Complementary Medicines Information Resources: Summary Report. -: